Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,900.00

Mettler-Toledo International (NYSE:MTD) had its target price raised by Stifel Nicolaus from $1,600.00 to $1,900.00 in a research report released on Monday morning,Benzinga reports. The firm currently has a buy rating on the medical instruments supplier’s stock.

Several other research analysts have also commented on the company. Robert W. Baird raised their price target on Mettler-Toledo International from $1,608.00 to $1,815.00 and gave the stock a “neutral” rating in a research report on Monday. Royal Bank Of Canada initiated coverage on Mettler-Toledo International in a research note on Tuesday, September 1st. They issued a “sector perform” rating and a $1,515.00 price objective for the company. Barclays boosted their price objective on Mettler-Toledo International from $1,575.00 to $1,700.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Rothschild & Co Redburn started coverage on Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 target price on the stock. Finally, Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Six equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,595.77.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,750.03 on Monday. The company has a debt-to-equity ratio of 25.28, a quick ratio of 0.75 and a current ratio of 1.10. The stock has a market capitalization of $34.81 billion, a P/E ratio of 37.83, a PEG ratio of 3.49 and a beta of 1.16. The company has a 50 day moving average price of $1,546.33 and a 200 day moving average price of $1,350.82. Mettler-Toledo International has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,806.58.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share for the quarter, beating the consensus estimate of $12.13 by $0.44. The firm had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.07 billion. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $11.15 EPS. Equities research analysts forecast that Mettler-Toledo International will post 47.83 EPS for the current year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 435 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $1,734.05, for a total transaction of $754,311.75. Following the sale, the insider directly owned 259 shares of the company’s stock, valued at $449,118.95. This represents a 62.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick Kaltenbach sold 942 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the sale, the chief executive officer directly owned 4,480 shares in the company, valued at approximately $6,384,000. The trade was a 17.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.71% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors have recently modified their holdings of the business. XXEC Inc. purchased a new stake in shares of Mettler-Toledo International during the second quarter worth $77,044,000. BlackRock Inc. acquired a new stake in shares of Mettler-Toledo International in the second quarter valued at $2,404,713,000. Bank of New York Mellon Corp acquired a new stake in shares of Mettler-Toledo International in the second quarter valued at $762,553,000. Wellington Management Group LLP raised its stake in shares of Mettler-Toledo International by 908.6% in the second quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock valued at $586,459,000 after acquiring an additional 413,547 shares in the last quarter. Finally, Aberdeen Group plc boosted its holdings in Mettler-Toledo International by 1,214.7% in the third quarter. Aberdeen Group plc now owns 245,978 shares of the medical instruments supplier’s stock valued at $371,660,000 after purchasing an additional 227,268 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.